Evidence map›Paper›PMID 28160089›Full record

ReviewWorld journal of urology2017

Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.

Helene Jung, Sero Andonian, Dean Assimos, Timothy Averch, Petrisor Geavlete, Yasuo Kohjimoto, Andreas Neisius, Joe Philip, Alberto Saita, Hemendra Shah and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 8 countries.

Helene JungUrological Research Center, Lillebaelt Hospital, University of Southern Denmark, Kabbeltoft 25, 7100, Vejle, Denmark.
Sero AndonianDepartment of Urology, McGill University, Montreal, QC, Canada.
Dean AssimosDepartment of Urology, U.A.B. School of Medicine, Birmingham, AL, USA.
Timothy AverchUPMC Department of Urology, Pittsburg, PA, USA.
Petrisor GeavleteDepartment of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania.
Yasuo KohjimotoDepartment of Urology, Wakayama Medical University, Kimiidera, Wakayama, Japan.
Andreas NeisiusKlinik für Urologie, Universitätsmedizin Mainz, Mainz, Germany.
Joe PhilipBristol Urological Institute, Bristol, UK.
Alberto SaitaDepartment of Urology, Humanitas Research Hospital, Rozzano, Milan, Italy.
Hemendra ShahUrolab Superspeciality Clinic, Andheri, Mumbai, India.
Palle Jörn OstherUrological Research Center, Lillebaelt Hospital, University of Southern Denmark, Kabbeltoft 25, 7100, Vejle, Denmark. palle.joern.osther@rsyd.dk.
University of Southern Denmark · DKAt Bristol · GBClinical Emergency Hospital Bucharest · ROIRCCS Humanitas Research Hospital · ITKlinik und Poliklinik für Psychosomatische Medizin und Psychotherapie · DEMcGill University · CAPittsburg State University · USWakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this review was to provide current best evidence for evaluation, dietary, and medical management of patients with urolithiasis.

methodsLiterature addressing evaluation, dietary, and medical management of urolithiasis was searched. Papers were analyzed and rated according to level of evidence (LOE), whereupon a synthesis of the evidence was made. Grade of recommendation (GOR) was judged from individual clinical experience and knowledge of the evidence according to the Oxford Centre for Evidence-based Medicine.

resultsIt is obvious that different stone diseases influence the life of stone-forming individuals very differently, and that evaluation and medical management should be personalized according to risk of recurrence, severity of stone disease, presence of associated medical conditions, and patient's motivation. With regard to evaluation, dietary and medical management of patients with urolithiasis evidence from the literature suggest that selective metabolic evaluation may lead to rational dietary and medical management. Statements based on LOE and GOR are provided to guide clinical practice.

conclusionThe provided evidence for evaluation of patients with urolithiasis aims at defining patients at high risk for recurrent/complicated stone disease. Based on this approach, evidence-based dietary and medical management regimes are suggested.

Indexed as

AllopurinolDiet TherapyDisease ManagementDiureticsEvidence-Based MedicineFluid TherapyGout SuppressantsHumansInfrared RaysKidney CalculiPotassium CitratePractice Guidelines as TopicSodium Chloride Symporter InhibitorsSpectrum AnalysisTomography, X-Ray ComputedUltrasonographyAllopurinolDiureticsGout SuppressantsPotassium CitrateSodium Chloride Symporter InhibitorsDietFollow-upImagingKidney calculiMetabolic evaluationPharmacologic interventionPrevention

Identifiers

PMID28160089
OpenAlexW2583414837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.